Exclusive Interviews

In part 1 of this Exclusive Interview, Jeffrey Emmick talks with Diabetes in Control Medical Editor Joy Pape about various products Lilly has brought to market and new products in development.

In part 2 of this Exclusive Interview, Jeffrey Emmick talks with Diabetes in Control Medical Editor Joy Pape about the combination of GLP1s and SGLTs while Diabetes in Control Publisher Steve Freed makes a quick appearance to ask about the possible effects of their combined use.

Tim Dunn, Ph.D., is the director of Clinical and Computational Research and an Abbott Volwiler Research Fellow.  He also serves as Chair of the Scientific Research Review Committee for investigator-initiated studies. His major areas of expertise are clinical trial strategy and trial design and real-world data analysis.

In this Exclusive Interview transcript, Tim Dunn talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about Abbott's research on CGM use and how the FreeStyle Libre system is helping a variety of patients with diabetes.

In this Exclusive Interview, Tim Dunn talks with Diabetes in Control Publisher Steve Freed during the ADA 2018 convention in Orlando about the work of Abbott on CGM use and how the FreeStyle Libre system is helping a variety of patients with diabetes.

In part 1 of this Exclusive Interview, Tim Dunn discusses the various abstracts on CGM use as presented by Abbott in a talk with Diabetes in Control Publisher Steve Freed.

In part 2 of this Exclusive Interview, Tim Dunn talks with Diabetes in Control Publisher Steve Freed about the CGM as more than a tool but as a form of treating diabetes.

In part 3 of this Exclusive Interview, Tim Dunn addresses ways for patients to handle the cost of a CGM in a talk with Diabetes in Control Publisher Steve Freed.

In part 4 of this Exclusive Interview, Tim Dunn discusses the success of the use of the FreeStyle Libre among youth in a talk with Diabetes in Control Publisher Steve Freed.

In part 5 of this Exclusive Interview, Tim Dunn talks with Diabetes in Control Publisher Steve Freed about software that can help medical professionals to interpret the data of the CGM system.